乳腺癌和其他癌症中的细胞染色体CYP4
Gloria M Calaf1, Leodan A Crispin1, Felipe Ossandon-Acosta2
1Instituto de Alta Investigación, Universidad de Tarapacá, Arica 1000000, Chile.
Biology
|July 29, 2025
概括
包括CYP4B1,CYP4F12和CYP4F3在内的CYP4酶家族与乳腺癌基因和雌激素受体具有复杂的相互作用. 这些发现表明,乳腺癌具有作为生物标志物和治疗点的潜力.
科学领域:
- 生物化学 生物化学
- 遗传学 是一个遗传学.
- 在瘤学瘤学.
背景情况:
- 乳腺癌是全世界女性死亡的主要原因之一.
- 细胞染色体P450 (CYP) 酶与癌症发生有关.
- 在癌症生物学中CYP4家族的作用正在引起人们的注意.
研究的目的:
- 研究特定的CYP4基因 (CYP4B1,CYP4F12,CYP4F3) 对乳腺癌的影响.
- 为了突出CYP酶和雌激素受体在乳腺癌中的相互作用.
- 确定潜在的预测生物标志物和治疗点.
主要方法:
- 对基因表达和相关性的生物信息分析.
- 检查整个器官和癌症类型的CYP基因表达特征.
主要成果:
- 在基底亚型中,CYP4B1与ESR1相关.
- CYP4F12与BRCA1 (Luminal B) 和ESR1 (基底亚型) 相对应.
- CYP4F3与多个亚型的BRCA1和BRCA2以及ESR1.1显著相关.
结论:
- CYP4酶在乳腺癌中发挥着功能性作用.
- 在CYP4基因,BRCA1 / 2和ESR1.1之间存在复杂的相互作用.
- 这些CYP4基因代表特定乳腺癌亚型的潜在生物标志物和治疗点.
相关概念视频
Electron Transport Chain: Complex I and II
15.0K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
15.0K
Inhibition of Cdk Activity
4.9K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.9K
Adaptive Mechanisms in Cancer Cells
5.9K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.9K
Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
Cancer-Critical Genes I: Proto-oncogenes
9.2K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
9.2K
Combination Therapies and Personalized Medicine
5.1K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.1K


